Novel Purification Approach & Tools to Define mRNA Specifications, Quality & Manufacturing

Time: 3:30 pm
day: Day Two


  • How to effectively define contaminant types and purity profiles in raw materials, process and overall drug substance?
  • Unravelling end-to-end purification workflow for mRNA drug substance following the IVT reaction
  • How to define suitable purification profile differences and consistency between therapies that are in line with regulatory expectations?